A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias

2011205 citationsJournal Articlebronze Open Access

Authors

Michael Strupp

R. Kalla · Ludwig-Maximilians-Universität München

Jens Claaßen · Ludwig-Maximilians-Universität München

Christine Adrion · Universität Ulm

Ulrich Mansmann · Universität Ulm

Thomas Klopstock · Ludwig-Maximilians-Universität München

Tobias Freilinger · Universität Ulm

Abstract

This crossover study provides Class II evidence that 4AP decreases attack frequency and improves the patient-reported quality of life in patients with episodic ataxia and related familial ataxias.

Topics & Keywords

Genetic Neurodegenerative Diseases Neurological disorders and treatments Vestibular and auditory disorders

Publication Details

Published in: Neurology

Volume 77, Issue 3, pp. 269-275

DOI: 10.1212/wnl.0b013e318225ab07

Field-Weighted Citation Impact: 6.65

Command Palette

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias

Authors

Abstract

Topics & Keywords

Publication Details